[18F]AlF-NOTA-MAL-Cys39-exendin-4

N/A

Report date: 2025/11/20 16:03:58

NME

Base Information

Drug Name[18F]AlF-NOTA-MAL-Cys39-exendin-4

Drug Alias Name[(18)F]AlF-NOTA-MAL-Cys(39)-exendin-4

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsInsulinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiangsu Provincial People'S Hospital (The First Affiliated Hospital Of Nanjing Medical University)

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Provincial People'S Hospital (The First Affiliated Hospital Of Nanjing Medical University)

Inactive CompaniesN/A

Active IndicationsInsulinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A